Angela DeMichele, MD, MSCE, FASCO, is a medical oncologist and molecular epidemiologist specializing in breast oncology. She is a Professor of Medicine and Epidemiology at the University of Pennsylvania Perelman School of Medicine and serves as Director of Clinical/Translational Research in Solid Oncology in the Division of Hematology/Oncology. She also holds the Mariann T. and Robert J. MacDonald Chair in Breast Cancer Research and co-leads the Breast Cancer Research Program at the Abramson Cancer Center. Dr. DeMichele’s clinical work centers on systemic therapy across the treatment continuum, including neoadjuvant and adjuvant care, as well as precision approaches incorporating targeted and immunotherapy strategies. Her research focuses on minimal and molecular residual disease monitoring and interception, biomarker and liquid biopsy development for treatment guidance, and molecular epidemiology to understand predictors of outcome and therapeutic response. Her leadership includes serving as 2024 Scientific Program Chair for ASCO, chairing the ECOG/ACRIN Cooperative Group Breast Committee, and leading trial operations for the I-SPY2 multicenter clinical trial, in addition to directing the Breast Cancer Clinical Research Unit and the Breast Cancer TRACR Biobank. She has been recognized with honors including the Gianni Bonadonna Breast Cancer Award, the Potamkin Prize for Breast Cancer Research, and designation as a Komen Scholar, and she serves in editorial leadership for journals including Breast Cancer Research. She earned her MD from Washington University School of Medicine, completed an internal medicine residency at the Hospital of the University of Pennsylvania, fellowship training in hematology and medical oncology at the University of Pennsylvania, and an MSCE at the University of Pennsylvania.
Professor
Medical School
1988 – 1991
Residency
1991 – 1992
Fellowship
1994 – 1995